摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-2-(2'-deoxy-β-D-erythro-pentafuranosyl)-2H-pyrazolo<3,4-d>pyrimidine | 99272-48-7

中文名称
——
中文别名
——
英文名称
4-amino-2-(2'-deoxy-β-D-erythro-pentafuranosyl)-2H-pyrazolo<3,4-d>pyrimidine
英文别名
4-amino-2-(2-deoxy-β-D-erythro-pentofuranosyl)-2H-pyrazolo<3,4-d>pyrimidine;8-aza-7-deaza-2'-deoxyadenosine, N8-linked;N8c7z8Ad;4-amino-2-(2-deoxy-β-D-erythro-pentofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine;(2R,3S,5R)-5-(4-aminopyrazolo[3,4-d]pyrimidin-2-yl)-2-(hydroxymethyl)oxolan-3-ol
4-amino-2-(2'-deoxy-β-D-erythro-pentafuranosyl)-2H-pyrazolo<3,4-d>pyrimidine化学式
CAS
99272-48-7
化学式
C10H13N5O3
mdl
——
分子量
251.245
InChiKey
RWOPHLREWURYIP-XLPZGREQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    198 °C
  • 沸点:
    633.5±55.0 °C(predicted)
  • 密度:
    1.91±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    119
  • 氢给体数:
    3
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Facile Synthesis of 2?-Deoxyribofuranosides of Allopurinol and 4-Amino-1H-pyrazolo[3,4-d]pyrimidinevia Phase-Transfer Glycosylation
    作者:Frank Seela、Herbert Steker
    DOI:10.1002/hlca.19850680305
    日期:1985.5.15
    Phase-transfer glycosylation of 4-methoxy-1H-pyrazolo[3,4-d]pyrimidine with the 2-deoxyribofuranosyl chloride 9 formed the N(1)-β-nucleoside 10a as main product (39%). As by-products the α-D-anomer 11a (7%) and the N(2)-isomer 12a (18%) were isolated. Assignment of these isomers was made on the basis of their 1H- and 13C-NMR spectra. Removal of the sugar-protecting groups yielded the 4-methoxy-nucleosides
    4-甲氧基-1 H-吡唑并[3,4- d ]嘧啶与2-脱氧呋喃呋喃糖基氯9的相转移糖基化反应形成N(1)-β-核苷10a为主要产物(39%)。作为副产物,分离出α-D-异构体11a(7%)和N(2)-异构体12a(18%)。这些异构体的分配基于其1 H-和13 C-NMR光谱进行。除去糖保护基团分别得到4-甲氧基核苷10b,11b和12b。4-MeO-基团的亲核取代产生别嘌呤醇的2-脱氧核糖呋喃糖苷1-4和4-氨基-1H-吡唑并[3,4- d ]嘧啶。
  • N8- and C8- linked purine bases as universal nucleosides used for oligonucleotide hybridization
    申请人:Roche Diagnostics GmbH
    公开号:EP1138688A1
    公开(公告)日:2001-10-04
    The present invention is directed to a nucleic acid binding compound comprising N8- or C8-linked purine bases or structurally related heterocycles, a compound useful for the preparation of such compound, a binding product of this nucleic acid binding compound with a nucleic acid, a method for the determination of a nucleic acid using said compound, and several uses of 8-linked purine bases and structurally related heterocycles. Compounds according to the present invention have advantageous properties when used in hybridization methods.
    本发明涉及一种核酸结合化合物,该化合物包含 N8-或 C8-连接的嘌呤碱基或结构相关的杂环,一种用于制备这种化合物的化合物,这种核酸结合化合物与核酸的结合产物,一种使用所述化合物测定核酸的方法,以及 8-连接的嘌呤碱基和结构相关的杂环的几种用途。根据本发明的化合物在杂交方法中使用时具有优势特性。
  • N8- and C8-linked purine bases as universal nucleosides used for oligonucleotide hybridization
    申请人:Roche Diagnostics GmbH
    公开号:EP1138689A1
    公开(公告)日:2001-10-04
    The present invention is directed to a nucleic acid binding compound comprising N8- or C8-linked purine bases or structurally related heterocycles, a compound useful for the preparation of such compound, a binding product of this nucleic acid binding compound with a nucleic acid, a method for the determination of a nucleic acid using said compound, and several uses of 8-linked purine bases and structurally related heterocycles. Compounds according to the present invention have advantageous properties when used in hybridization methods.
    本发明涉及一种核酸结合化合物,该化合物包含 N8-或 C8-连接的嘌呤碱基或结构相关的杂环,一种用于制备这种化合物的化合物,这种核酸结合化合物与核酸的结合产物,一种使用所述化合物测定核酸的方法,以及 8-连接的嘌呤碱基和结构相关的杂环的几种用途。根据本发明的化合物在杂交方法中使用时具有优势特性。
  • Base-Pairing Properties of 8-Aza-7-deazaadenine Linked via the 8-Position to the DNA Backbone
    作者:Frank Seela、Matthias Zulauf、Harald Debelak
    DOI:10.1002/1522-2675(20000705)83:7<1437::aid-hlca1437>3.0.co;2-u
    日期:2000.7.5
    The base-pairing properties of oligonucleotides containing the unusual N-8-linked 8-aza-7-deazaadenine 2'-deoxyribonucleoside (2a) as well as its 7-bromo derivative 2b are described. The oligonucleotides were prepared by solid-phase synthesis employing phosphoramidite chemistry. Compound 2a forms a strong base pair with T-d for which a reverse Watson-Crick pair is suggested (Fig. 9). Compound 2a displays a lower N-glycosylic-bond stability than its Ng-nucleoside and shows strong stacking interactions when incorporated into oligonucleotides. The replacement of 2'-deoxyadenosine by 2a does not significantly influence the duplex stability. However, this behavior depends on the position of the incorporation.
  • SEELA, F.;DRILLER, H.;KAISER, K.;ROSEMEYER, H.;STEKER, H., NUCLEOSIDES AND NUCLEOTIDES, 8,(1989) N-6, C. 789-792
    作者:SEELA, F.、DRILLER, H.、KAISER, K.、ROSEMEYER, H.、STEKER, H.
    DOI:——
    日期:——
查看更多

同类化合物

阿拉格列汀 间型霉素环-3',5'-单磷酸酯 西地那非杂质 苯,[(1-甲基环戊基)硫代]- 苄基-(6-氯-1-甲基-1H-吡唑并[3,4-d]嘧啶-4-基)-胺 甲基-(6-甲基磺酰基-1(2)H-吡唑并[3,4-d]嘧啶-4-基)-胺 环己基-(1-甲基-1H-吡唑并[3,4-d]嘧啶-4-基)-胺 氮杂环庚-1-基-[7-氯-4-噻吩-2-基-2-(三氟甲基)-1,5,9-三氮杂双环[4.3.0]壬-2,4,6,8-四烯-8-基]甲酮 异丙基 4-(1-甲基-7-氧代-3-丙基-6,7-二氢-1H-吡唑并[4,3-d]嘧啶-5-基)噻吩-2-基磺酰基氨基甲酸酯 吡啶-2-基-[7-吡啶-4-基-吡唑[1,5-a]嘧啶-3-基]甲酮 吡唑并[2,3-a]嘧啶 吡唑并[1,5-a]嘧啶-7-胺 吡唑并[1,5-a]嘧啶-7(1h)-酮 吡唑并[1,5-a]嘧啶-6-醇 吡唑并[1,5-a]嘧啶-6-羧酸乙酯 吡唑并[1,5-a]嘧啶-6-羧酸 吡唑并[1,5-a]嘧啶-5-羧酸 吡唑并[1,5-a]嘧啶-3-胺盐酸盐(1:1) 吡唑并[1,5-a]嘧啶-3-胺;三氟乙酸 吡唑并[1,5-a]嘧啶-3-羰酰氯 吡唑并[1,5-a]嘧啶-3-羧酸乙酯 吡唑并[1,5-a]嘧啶-3-羧酸 吡唑并[1,5-a]嘧啶-3-磺酰胺 吡唑并[1,5-a]嘧啶-3-甲酰胺 吡唑并[1,5-a]嘧啶-3-甲腈 吡唑并[1,5-a]嘧啶-2-羧酸乙酯 吡唑并[1,5-a]嘧啶-2-羧酸 吡唑并[1,5-a]嘧啶,2-甲基-6-(1-甲基乙基)- 吡唑并[1,5-a]嘧啶,2-溴-5,7-二甲基- 吡唑并[1,5-A]嘧啶-5-胺 吡唑并[1,5-A]嘧啶-5(4H)-酮 吡唑并[1,5-A]嘧啶-3-甲醛 吡唑[1,5-A]嘧啶-5-羧酸甲酯 吡唑[1,5-A]嘧啶-5,7(4H,6H)-二酮 双氯地那非 别嘌醇 别嘌呤醇D2 二硫代乙基碳萘甲醚 二硫代-脱甲基-昔多芬 乙基7-甲基吡唑并[1,5-a]嘧啶-6-羧酸酯 [1,2]恶唑并[4,3-e]吡唑并[1,5-A]嘧啶 [(2S,5R)-5-(4-氨基-1H-吡唑并[3,4-d]嘧啶-1-基)四氢呋喃-2-基]甲醇 VEGFR2激酶抑制剂IV N5-(6-氨基己基)-N7-苄基-3-异丙基吡唑并[1,5-a]嘧啶-5,7-二胺 N5-(1-环庚基-1H-吡唑并[3,4-d]嘧啶-6-基)吡啶-2,5-二胺 N3-(4-氟苯基)-1H-吡唑并[3,4-D]嘧啶-3,4-二胺 N-苄基-6-氯-1H-吡唑并[3,4-d]嘧啶-4-胺 N-苄基-1H-吡唑并[3,4-d]嘧啶-4-胺 N-甲基-1H-吡唑并[3,4-d]嘧啶-4-胺 N-[2-(3-氨基-3-氧代丙氧基)乙基]-6-(4-溴苄基)吡唑并[1,5-a]嘧啶-3-甲酰胺